a case of paraneoplastic cerebellar ataxia syndrome associated with immunocheckpoint inhibitor treated with Ofatumumab
Journal Title: Chinese Journal of Nervous and Mental Diseases - Year 2024, Vol 50, Issue 3
Abstract
A case of paraneoplastic cerebellar ataxia syndrome caused by immune checkpoint inhibitors (ICI) was treated with ofatumumab (OFA). The patient is a 57-year-old male. He used “Camrelizumab” immunotherapy for his previous history of small cell lung cancer. The main reason was “walking unsteadily for more than one year and shaking his head involuntarily for more than one month”. After admission, the head MRI, chest CT, electroencephalogram, lumbar puncture and other related examinations were improved. The antibody spectrum of paraneoplastic neurological syndrome was anti-GAD65 antibody IgG(+), and the case was then diagnosed as the immune checkpoint inhibitor-related paraneoplastic neurological syndromes(PNS) of nervous system. After OFA treatment (20 mg/time), the symptoms were obviously improved. This paper analyzes the clinical features and diagnosis and treatment approaches of this case, in order to improve clinicians' understanding of the disease and provide reference for clinical diagnosis and treatment of similar cases.
Authors and Affiliations
Yajing LIU, Shuanghao FENG, Jiajia JIANG, Yi YANG, Hui. BU
Keywords
Related Articles
- EP ID EP750449
- DOI 10.3969/j.issn.1002-0152.2024.03.007
- Views 38
- Downloads 0
Influence factors of comorbidity between gaming disorder and depression among adolescents
The comorbidity of online game disorder and depression has become a universal problem in the world, which seriously affects the physical and mental health of teenagers. Online game disorder closely relate to depression o...
A metabolome-wide case-control study of social anxiety disorder in patients with schizophrenia
[Objective] To explore the metabolic markers of social anxiety disorder in schizophrenia patients with social anxiety disorder through metabolomic sequencing analysis. [Methods] From December 2022 to December 2023, a cas...
A comprehensive report on the clinical, pathological, and genetic characteristics of Stormorken syndrome attributed to a STIM1 gene mutation, diagnosed in adulthood
To report a case of Stormorken syndrome (STRMK) diagnosed in adulthood and to study its clinical, pathological and genetic characteristics. The individual was a 31-year-old male whose symptoms started from childhood with...
Research progress on autoimmune glial fibrillary acidic protein astrocytopathy
Autoimmune glial fibrillary acidic protein astropathy (GFAP-A) is an autoimmune inflammatory disease of the central nervous system, with a prevalence rate of 0.6 per 100,000. Its clinical manifestations include subacute...
Research progress of cognitive impairment in patients with attenuated psychosis syndrome
Attenuated psychosis syndrome (APS) is a clinical disorder associated with a high risk of psychosis. Patients during this period typically exhibit multidimensional neurocognitive and social cognitive impairment. Cognitiv...